Kalium Chloratum Biomedica

Potassium Chloride, the active ingredient in Kalium Chloratum Biomedica, is an electrolyte / potassium supplement presented as an oral formulation for oral use. It is indicated to correct low serum potassium concentrations and to support normal electrolyte balance in patients at risk of hypokalemia, such as those receiving diuretics or experiencing gastrointestinal losses.

GNH USA supplies Kalium Chloratum Biomedica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring product quality and regulatory conformity across all markets.

Kalium Chloratum Biomedica, a potassium chloride electrolyte supplement, is used in conditions where potassium homeostasis is disrupted.

- Hypokalemia: restores serum potassium to normal levels, reducing risk of cardiac and muscular complications. - Potassium deficiency: replenishes body potassium stores after losses due to diarrhea, vomiting, or diuretic therapy. - Maintenance of normal potassium levels: provides ongoing supplementation for patients requiring long‑term potassium balance.

Oral potassium chloride may be associated with a range of adverse reactions, most of which are mild and dose‑related.

Common Side Effects: - Nausea: mild stomach upset that often resolves with continued use. - Abdominal discomfort: cramping or pain in the upper abdomen. - Diarrhea: loose stools occurring shortly after ingestion. - Taste disturbance: metallic or salty taste in the mouth. - Flatulence: increased gas production. - Headache: transient mild headache.

Serious or Rare Side Effects: - Hyperkalemia: excessively high serum potassium that can cause cardiac arrhythmia. - Cardiac arrhythmia: irregular heart rhythm, potentially life‑threatening. - Severe muscle weakness: marked reduction in muscle strength. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: rare severe skin reaction.

Before initiating therapy with Kalium Chloratum Biomedica, several safety considerations should be reviewed. - Monitor serum potassium: check levels prior to treatment and periodically during therapy. - Adjust dose in renal impairment: reduced kidney function may require lower dosing or increased monitoring. - Avoid use in hyperkalemia: patients with elevated potassium should not receive additional potassium chloride. - Caution with ACE inhibitors or potassium‑sparing diuretics: concurrent use can raise potassium excessively. - Pregnancy and lactation: safety not established; use only if potential benefit justifies risk. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Potassium chloride can interact with several medicines that affect potassium balance or cardiac function.

Major Interactions (Avoid): - ACE inhibitors: may cause additive hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of dangerous potassium elevation. - Trimethoprim‑sulfamethoxazole: can reduce renal potassium excretion. - NSAIDs: may impair renal potassium handling, enhancing hyperkalemia risk.

Moderate Interactions (Monitor Closely): - Digoxin: high potassium levels can reduce digoxin toxicity but low levels increase risk. - Beta‑blockers: may mask symptoms of hyperkalemia. - Lithium: altered renal clearance may affect lithium levels.